Hyperparathyroidism in a renal transplant patient: an unusual cause of resistance to therapy.
A long-term renal transplant patient who was regularly followed up in the transplant clinic with stable renal allograft function was found to have elevated parathyroid hormone (PTH) levels on a biointact PTH assay. The elevated PTH levels were resistant to suppression on increasing doses of 1-alfacalcidol. Detailed history taking and clinical examination revealed the reason for apparent resistance to therapy.
Department of Renal Medicine, South West Thames Renal and Transplantation Unit, St Helier Hospital, Carshalton, Surrey, UK. Nephr0nite@gmail.com
Subash
S
Somalanka
Mysore K
MK
Phanish
D001132:Arm; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D006961:Hyperparathyroidism / Q000188:drug therapy*; D016030:Kidney Transplantation; D008875:Middle Aged; D010280:Parathyroid Glands / Q000637:transplantation*; D018962:Phlebotomy / Q000379:methods
D050071:Bone Density Conservation Agents; D006887:Hydroxycholecalciferols; C008088:alfacalcidol